ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 580,03
-0,69%
Dow Jones
40 786,99
1,43%
DAX
18 518,03
-0,44%
Brent Oil
83,50
-1,00%
Bitcoin
64 479,21
-0,57%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NYSE
  6. Teva Pharmaceutical Industries Ltd (TEVA)

  7. Teva Pharmaceutical Industries Ltd (TEVA) Actualités

TEVA

Teva Pharmaceutical Indu... (TEVA)

Teva Pharmaceutical Industries Ltd
De:
Trier par:
 Showing the most relevant articles for your search:NYSE:TEVA
DateHeureSourceTitreSymboleSociété
11/11/201317h25Business WireTeva will pay the State of Israel NIS 2.540 billion ($718M)NYSE:TEVATeva Pharmaceutical Industries Ltd
08/11/201316h32Edgar (US Regulatory)Report of Foreign Issuer (6-k)NYSE:TEVATeva Pharmaceutical Industries Ltd
08/11/201314h00Business WireSurvey Data Reinforces Patient Benefit of Asthma Rescue Inhalers with Integrated Dose CountersNYSE:TEVATeva Pharmaceutical Industries Ltd
07/11/201323h13Dow Jones NewsCorrection to OncoGenex, Teva Earnings HeadlinesNYSE:TEVATeva Pharmaceutical Industries Ltd
07/11/201322h00PR Newswire (US)OncoGenex Pharmaceuticals, Inc. Reports Financial Results for Third Quarter 2013 and Addresses Key Questions from Investors o...NYSE:TEVATeva Pharmaceutical Industries Ltd
04/11/201319h17Business WireDiscovery Channel Documentary “Pain Matters” Chronicles the Burdens of Living with Chronic PainNYSE:TEVATeva Pharmaceutical Industries Ltd
01/11/201314h00Business WireTEVA SHAREHOLDER ALERT: The Law Firm of Wohl & Fruchter LLP is Investigating Teva Pharmaceutical Industries LimitedNYSE:TEVATeva Pharmaceutical Industries Ltd
31/10/201313h29Business WireTeva Reports Third Quarter 2013 ResultsNYSE:TEVATeva Pharmaceutical Industries Ltd
30/10/201322h54Dow Jones NewsADR Shares End Mixed Following Fed MeetingNYSE:TEVATeva Pharmaceutical Industries Ltd
30/10/201314h30Dow Jones NewsU.S. Hot Stocks Futures: Hot Stocks to WatchNYSE:TEVATeva Pharmaceutical Industries Ltd.
30/10/201310h57Business WireTeva Announces Departure of President and CEONYSE:TEVATeva Pharmaceutical Industries Ltd
14/10/201315h28Business WireTeva Announces FDA Approval of Generic TOBI® in the United StatesNYSE:TEVATeva Pharmaceutical Industries Ltd
10/10/201321h59Business WireTeva to Report Third Quarter 2013 Financial Results on October 31, 2013NYSE:TEVATeva Pharmaceutical Industries Ltd
10/10/201313h07Business WireTeva Accelerates Cost Reduction ProgramNYSE:TEVATeva Pharmaceutical Industries Ltd
04/10/201315h45Business WireNew Data Presented at 29th ECTRIMS Congress Reinforce the Clinical Profile of Investigational Laquinimod on Disease Progressi...NYSE:TEVATeva Pharmaceutical Industries Ltd
03/10/201320h16Business WireTeva Announces Favorable Ruling on COPAXONE Patent Litigation in the NetherlandsNYSE:TEVATeva Pharmaceutical Industries Ltd
03/10/201316h12Business WireTeva to Present Further Results of Twenty-Year Open-Label Extension Study of Glatiramer Acetate 20 mg Daily for Relapsing-Rem...NYSE:TEVATeva Pharmaceutical Industries Ltd
01/10/201315h00Business WireTeva Announces Launch of Generic Zemplar® in the United StatesNYSE:TEVATeva Pharmaceutical Industries Ltd
01/10/201314h00Business WireNewly Published Phase III Exploratory Analysis Suggests Investigational Oral Laquinimod for Multiple Sclerosis May Reduce Bra...NYSE:TEVATeva Pharmaceutical Industries Ltd
30/09/201315h07Business WireTeva In-Focus: A New Webinar Series for the Investment Community Focusing on Teva’s R&D ActivitiesNYSE:TEVATeva Pharmaceutical Industries Ltd
26/09/201315h28Business WireNew Clinical Insights and Data Presented at 29th ECTRIMS Congress Further Advance Teva’s Leadership in Multiple SclerosisNYSE:TEVATeva Pharmaceutical Industries Ltd
24/09/201318h00PR Newswire (US)Teva Announces Quartette™ (levonorgestrel/ethinyl estradiol and ethinyl estradiol) Tablets Now Available for the Prevention...NYSE:TEVATeva Pharmaceutical Industries Ltd
24/09/201311h00Business WireTeva Announces Exclusive Launch of Generic ADENOSCAN® in the United StatesNYSE:TEVATeva Pharmaceutical Industries Ltd
24/09/201311h00Business WireTeva Announces Exclusive Launch of Generic ADENOSCAN® in the United StatesNYSE:TEVATeva Pharmaceutical Industries Ltd
23/09/201314h58Business WireTeva Announces Favorable Court Ruling in AZILECT® Patent Infringement Litigation Against MylanNYSE:TEVATeva Pharmaceutical Industries Ltd
23/09/201314h58Business WireTeva Announces Favorable Court Ruling in AZILECT® Patent Infringement Litigation Against MylanNYSE:TEVATeva Pharmaceutical Industries Ltd
20/09/201320h08Business WireCORRECTING and REPLACING Teva Announces Exclusive Launch of Generic NIASPAN® in the United StatesNYSE:TEVATeva Pharmaceutical Industries Ltd
20/09/201315h46Business WireTeva Announces Exclusive Launch of Generic NIASPAN® in the United StatesNYSE:TEVATeva Pharmaceutical Industries Ltd
17/09/201315h13Business WireFDA Approves Teva’s TREANDA® (bendamustine HCI) Injection, a New Liquid FormulationNYSE:TEVATeva Pharmaceutical Industries Ltd
17/09/201314h00PR Newswire (US)Teva Pharmaceuticals Donates to the National Multiple Sclerosis Society in recognition of Jack Osbourne as He Competes on "Da...NYSE:TEVATeva Pharmaceutical Industries Ltd
 Showing the most relevant articles for your search:NYSE:TEVA

Dernières Valeurs Consultées

EU
VIV
Vivendi
EU
PX1
CAC 40
EU
LR
Legrand
EU
EN
Bouygues
EU
AF
Air FranceKLM
NYSE
JPM
JP Morgan Chase
EU
ORA
Orange
COIN
ETHUSD
Ethereum
EU
CAP
Capgemini
EU
RI
Pernod Ricard
EU
BNP
BNP Paribas
EU
CS
Axa
NYSE
KO
Coca Cola
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés